The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 Mn in 2017. The market is estimated to grow with a CAGR of 9.1% from 2018-2025.
dPCR and qPCR are PCR technology which have evolved over the years from thermostable polymerases, development of automated thermocyclers to latest digital PCR (d-PCR) methodologies. However, the basic principle of denature, anneal, extend remains the same. qPCR has spawned the second generation that allows analysis and diagnosis with reduced risk of contamination and is considered as ‘gold standard’. dPCR amplifies the target DNA molecule and quantifies directly without external calibrator.
Download Sample Copy of This Report @ https://www.theinsightpartners.com/sample/TIPHE100000817/
This has been used extensively for studying variations in gene sequences. With these numerous advantages the market is expected to witness rapid growth. The growth of the dPCR and qPCR in healthcare market is attributed to the Increasing Incidence of Genetic Diseases, Increase in Investments & Funds for Gene Synthesis, Technological Advancements in PCR Technologies are key drivers for the growth of the market. However, factors such as High Costs of PCR Systems and Technical Limitations Associated with qPCR are likely to restrain the market growth to a certain extent.
The prominent players operating in the market of dPCR and qPCR across the globe includes Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies, Inc., bioMérieux SA, Danaher, and Fluidigm Corporation among others. For instance, in July 2017 Agilent Technologies Inc. expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic use. And the launch expanded the business of the company in global dPCR and qPCR market.
Research study is a highly acclaimed resource that investors, market contestants, and other people interested in this dPCR and qPCR report can use to intensely position themselves in the global dPCR and qPCR market. It mentions the recent developments structures, future growth plans, and other significant aspects of the business key participants that define their growth in the global dPCR and qPCR market.
The dPCR and qPCR in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide.
dPCR and qPCR Industry research report is a meticulous investigation of the current scenario of the dPCR and qPCR global and regional market, which covers several industry dynamics. The dPCR and qPCR market research report is a resource, which provides current as well as upcoming technical and financial details with market risk, growing demand and raw materials. The thorough analysis in this report enables investors, CEOs, regional traders, suppliers, top vendors to understand the market in a better way and based on that knowledge make well-informed decisions.
Place a Direct Order of this Report – https://www.theinsightpartners.com/buy/TIPHE100000817/
Note: If you have any special requirements related to dPCR and qPCR Market Report please let us know and we will offer you the report as you want.
About us: –
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defence.